Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab, Bevacizumab and Memantine in Hepatocellular Carcinoma
NCT06789757Phase 2Recruiting
- Sponsor
- Inova Health System
- Start
- Feb 2025
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in hepatocellular carcinoma (HCC), sponsored by Inova Health System. Started Feb 2025; status: recruiting.
02
Drugs
memantine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06789757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789757.